Joon Hee Kang

784 total citations
27 papers, 577 citations indexed

About

Joon Hee Kang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joon Hee Kang has authored 27 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joon Hee Kang's work include Cancer, Hypoxia, and Metabolism (14 papers), Blood properties and coagulation (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Joon Hee Kang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (14 papers), Blood properties and coagulation (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Joon Hee Kang collaborates with scholars based in South Korea and United States. Joon Hee Kang's co-authors include Seon-Hyeong Lee, Soo‐Youl Kim, Jae‐Seon Lee, Hyonchol Jang, Ho Lee, Soo‐Youl Kim, Jaewhan Song, Kyeong Man Hong, Jaekyoung Son and Cheolju Lee and has published in prestigious journals such as Cancer Research, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Joon Hee Kang

25 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joon Hee Kang South Korea 15 349 297 78 77 56 27 577
Martina Takáčová Slovakia 15 422 1.2× 236 0.8× 68 0.9× 75 1.0× 61 1.1× 31 606
Seon-Hyeong Lee South Korea 16 439 1.3× 295 1.0× 119 1.5× 87 1.1× 86 1.5× 29 705
Xiphias Ge Zhu United States 7 516 1.5× 307 1.0× 60 0.8× 90 1.2× 51 0.9× 7 719
Gina N. Alesi United States 7 612 1.8× 474 1.6× 124 1.6× 148 1.9× 61 1.1× 9 898
Qingang Wu China 8 351 1.0× 227 0.8× 41 0.5× 113 1.5× 35 0.6× 10 567
Luca X. Zampieri Belgium 12 387 1.1× 249 0.8× 57 0.7× 103 1.3× 22 0.4× 13 572
Joo Hye Yeo South Korea 7 319 0.9× 269 0.9× 56 0.7× 90 1.2× 31 0.6× 13 512
Ufuk Degirmenci Singapore 7 480 1.4× 222 0.7× 57 0.7× 128 1.7× 30 0.5× 7 653
Shamir Cassim France 14 407 1.2× 281 0.9× 104 1.3× 149 1.9× 36 0.6× 17 696
Simon Schwörer United States 9 502 1.4× 268 0.9× 127 1.6× 148 1.9× 41 0.7× 9 794

Countries citing papers authored by Joon Hee Kang

Since Specialization
Citations

This map shows the geographic impact of Joon Hee Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joon Hee Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joon Hee Kang more than expected).

Fields of papers citing papers by Joon Hee Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joon Hee Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joon Hee Kang. The network helps show where Joon Hee Kang may publish in the future.

Co-authorship network of co-authors of Joon Hee Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Joon Hee Kang. A scholar is included among the top collaborators of Joon Hee Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joon Hee Kang. Joon Hee Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Ho Jeong, Soyeong Sim, Joon Hee Kang, et al.. (2025). ACAA1 knockout increases the survival rate of KPC mice by activating autophagy. Molecular Metabolism. 100. 102237–102237.
2.
Woo, Sang Myung, Ho Lee, Joon Hee Kang, et al.. (2025). Loss of SLC25A20 in Pancreatic Adenocarcinoma Reversed the Tumor-Promoting Effects of a High-Fat Diet. Theranostics. 15(13). 6516–6533. 2 indexed citations
3.
Kang, Su-Min, Joon Hee Kang, Seung‐Il Kim, et al.. (2024). In-plane seismic performance of precast concrete hollow-core slab panels for basement walls. Structures. 63. 106478–106478. 1 indexed citations
4.
Kang, Joon Hee, Hyeon Joo Kim, Eunji Im, et al.. (2023). Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinoma. Bioorganic Chemistry. 143. 107061–107061.
5.
Kang, Joon Hee, Suji Han, Hyonchol Jang, et al.. (2023). Glucose Deprivation Induces Cancer Cell Death through Failure of ROS Regulation. International Journal of Molecular Sciences. 24(15). 11969–11969. 21 indexed citations
6.
Lee, Jae‐Seon, Jiwon Choi, Seon-Hyeong Lee, et al.. (2020). Oxoglutarate Carrier Inhibition Reduced Melanoma Growth and Invasion by Reducing ATP Production. Pharmaceutics. 12(11). 1128–1128. 9 indexed citations
7.
Lee, Ho, Hyonchol Jang, Sang Myung Woo, et al.. (2020). Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling. Cells. 9(9). 2013–2013. 40 indexed citations
8.
Lee, Seon-Hyeong, Yoon Jeon, Joon Hee Kang, et al.. (2020). The Combination of Loss of ALDH1L1 Function and Phenformin Treatment Decreases Tumor Growth in KRAS-Driven Lung Cancer. Cancers. 12(6). 1382–1382. 12 indexed citations
9.
Lee, Jae‐Seon, Soo Jin Oh, Hyun-Jung Choi, et al.. (2020). ATP Production Relies on Fatty Acid Oxidation Rather than Glycolysis in Pancreatic Ductal Adenocarcinoma. Cancers. 12(9). 2477–2477. 43 indexed citations
10.
Kang, Joon Hee, Seon-Hyeong Lee, Jae‐Seon Lee, et al.. (2020). Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma. Cells. 9(6). 1475–1475. 7 indexed citations
11.
Lee, Jae‐Seon, et al.. (2019). Gastric cancer depends on aldehyde dehydrogenase 3A1 for fatty acid oxidation. Scientific Reports. 9(1). 16313–16313. 31 indexed citations
12.
Lee, Jae‐Seon, Ho Lee, Joon Hee Kang, et al.. (2019). Loss of SLC25A11 causes suppression of NSCLC and melanoma tumor formation. EBioMedicine. 40. 184–197. 38 indexed citations
13.
Kim, Nayeon, Joon Hee Kang, Won‐Kyu Lee, et al.. (2018). Allosteric inhibition site of transglutaminase 2 is unveiled in the N terminus. Amino Acids. 50(11). 1583–1594. 13 indexed citations
14.
Seo, Jinho, et al.. (2018). Targeting Mitochondrial Oxidative Phosphorylation Abrogated Irinotecan Resistance in NSCLC. Scientific Reports. 8(1). 15707–15707. 37 indexed citations
15.
Lee, Seon-Hyeong, Won‐Kyu Lee, Nayeon Kim, et al.. (2018). Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition. Cancers. 10(11). 455–455. 21 indexed citations
16.
Park, Junseong, Joon Hee Kang, Eui Hyun Kim, et al.. (2017). METB-15. REGULATION OF BIOENERGETICS THROUGH DUAL INHIBITION OF ALDEHYDE DEHYDROGENASE AND MITOCHONDRIAL COMPLEX I SUPPRESSES GLIOBLASTOMA TUMORSPHERES. Neuro-Oncology. 19(suppl_6). vi131–vi131. 1 indexed citations
17.
Kang, Joon Hee, Seon-Hyeong Lee, Dongwan Hong, et al.. (2016). Aldehyde dehydrogenase is used by cancer cells for energy metabolism. Experimental & Molecular Medicine. 48(11). e272–e272. 64 indexed citations
18.
Kang, Joon Hee, Seon-Hyeong Lee, Dongwan Hong, et al.. (2016). Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC. Cell Death and Disease. 7(12). e2511–e2511. 41 indexed citations
19.
Lee, Jae‐Seon, Joon Hee Kang, Seon-Hyeong Lee, et al.. (2016). Glutaminase 1 inhibition reduces thymidine synthesis in NSCLC. Biochemical and Biophysical Research Communications. 477(3). 374–382. 19 indexed citations
20.
Lee, Eun Ji, Hyun Ji Kim, Joon Hee Kang, et al.. (2012). Histamine receptor 2-mediated growth-differentiation factor-15 expression is involved in histamine-induced melanogenesis. The International Journal of Biochemistry & Cell Biology. 44(12). 2124–2128. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026